- Home
- CNTX vs SOTK Comparison
CNTX vs SOTK Comparison
Compare CNTX & SOTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- SOTK
- Stock Information
- Founded
- CNTX 2015
- SOTK 1975
- Country
- CNTX United States
- SOTK United States
- Employees
- CNTX N/A
- SOTK N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- SOTK Industrial Machinery/Components
- Sector
- CNTX Health Care
- SOTK Technology
- Exchange
- CNTX Nasdaq
- SOTK Nasdaq
- Market Cap
- CNTX 77.2M
- SOTK 61.8M
- IPO Year
- CNTX 2021
- SOTK 1987
- Fundamental
- Price
- CNTX $0.96
- SOTK $3.91
- Analyst Decision
- CNTX Strong Buy
- SOTK Buy
- Analyst Count
- CNTX 5
- SOTK 1
- Target Price
- CNTX $6.70
- SOTK $7.50
- AVG Volume (30 Days)
- CNTX 1.1M
- SOTK 31.9K
- Earning Date
- CNTX 11-06-2024
- SOTK 01-13-2025
- Dividend Yield
- CNTX N/A
- SOTK N/A
- EPS Growth
- CNTX N/A
- SOTK N/A
- EPS
- CNTX N/A
- SOTK 0.07
- Revenue
- CNTX N/A
- SOTK $20,151,145.00
- Revenue This Year
- CNTX N/A
- SOTK $6.11
- Revenue Next Year
- CNTX N/A
- SOTK $9.27
- P/E Ratio
- CNTX N/A
- SOTK $57.01
- Revenue Growth
- CNTX N/A
- SOTK 8.40
- 52 Week Low
- CNTX $0.89
- SOTK $3.50
- 52 Week High
- CNTX $2.75
- SOTK $6.07
- Technical
- Relative Strength Index (RSI)
- CNTX 38.22
- SOTK 44.52
- Support Level
- CNTX $0.92
- SOTK $3.71
- Resistance Level
- CNTX $1.05
- SOTK $4.59
- Average True Range (ATR)
- CNTX 0.13
- SOTK 0.44
- MACD
- CNTX 0.01
- SOTK -0.01
- Stochastic Oscillator
- CNTX 17.78
- SOTK 18.65
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About SOTK Sono-Tek Corporation
Sono-Tek Corp designs and manufactures ultrasonic coating systems that apply precise, thin film coatings to a multitude of products for the microelectronics/electronics, alternative energy, medical, and industrial markets, including specialized glass applications in construction and automotive. It sells products to emerging research and development and other markets. Its ultrasonic nozzle systems use high-frequency, ultrasonic vibrations that atomize liquids into minute drops that can be applied to surfaces at low velocity providing thin layers of protective materials over a surface such as glass or metals.